Loading viewer...
conference
Format: PDF conference
Regeneron Pharmaceuticals presented clinical and research advances in oncology and hematology at the 2023 American Society of Hematology conference. The presentation covered investigational bispecific antibodies including linvoseltamab for multiple myeloma and odronextamab for lymphomas, alongside classical hematology programs in complement inhibition, Factor XI antibodies, and genetic therapies.
investor_presentation
23 Pages
conference
1 Pages
Allianz SE
Herc Rentals 2021 Barclays Fireside Chat
conferenceconference
51 Pages
Herc Rentals Inc.
First Quantum Minerals Q2 2016 Conference Call
conferenceconference
23 Pages
First Quantum Minerals
J.B. Hunt Transport Services 2022 Industrial Conference
conferenceconference
21 Pages
J.B. Hunt Transport Services, Inc.